In a preclinical model, combining hemoglobin-loaded liposomes with chemotherapeutic agents effectively reduced MMP-2 expression and attenuated tumor invasiveness, suggesting that the indirect modulation of MMP activity through combination strategies may have therapeutic potential (104). This evidence concerns the gene MMP2 and neoplasm.